Free Trial
NYSE:RVTY

Revvity (RVTY) Stock Price, News & Analysis

Revvity logo
$108.60 +1.31 (+1.22%)
Closing price 03/24/2025 03:59 PM Eastern
Extended Trading
$109.04 +0.44 (+0.41%)
As of 03/24/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Revvity Stock (NYSE:RVTY)

Key Stats

Today's Range
$107.62
$110.13
50-Day Range
$106.96
$126.93
52-Week Range
$97.32
$129.50
Volume
702,732 shs
Average Volume
849,400 shs
Market Capitalization
$13.05 billion
P/E Ratio
49.14
Dividend Yield
0.26%
Price Target
$136.25
Consensus Rating
Moderate Buy

Company Overview

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Remove Ads

Revvity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

RVTY MarketRank™: 

Revvity scored higher than 68% of companies evaluated by MarketBeat, and ranked 300th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Revvity has received a consensus rating of Moderate Buy. The company's average rating score is 2.77, and is based on 8 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Revvity has only been the subject of 4 research reports in the past 90 days.

  • Read more about Revvity's stock forecast and price target.
  • Earnings Growth

    Earnings for Revvity are expected to grow by 12.55% in the coming year, from $4.94 to $5.56 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Revvity is 49.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.53.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Revvity is 49.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.70.

  • Price to Earnings Growth Ratio

    Revvity has a PEG Ratio of 3.82. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Revvity has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Revvity's valuation and earnings.
  • Percentage of Shares Shorted

    3.98% of the float of Revvity has been sold short.
  • Short Interest Ratio / Days to Cover

    Revvity has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Revvity has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Revvity has a dividend yield of 0.25%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Revvity does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Revvity is 12.67%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Revvity will have a dividend payout ratio of 5.04% next year. This indicates that Revvity will be able to sustain or increase its dividend.

  • Read more about Revvity's dividend.
  • Percentage of Shares Shorted

    3.98% of the float of Revvity has been sold short.
  • Short Interest Ratio / Days to Cover

    Revvity has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in Revvity has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Revvity has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for Revvity this week, compared to 7 articles on an average week.
  • Search Interest

    Only 2 people have searched for RVTY on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Revvity to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Revvity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,564,015.00 in company stock.

  • Percentage Held by Insiders

    Only 0.60% of the stock of Revvity is held by insiders.

  • Percentage Held by Institutions

    86.65% of the stock of Revvity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Revvity's insider trading history.
Receive RVTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revvity and its competitors with MarketBeat's FREE daily newsletter.

RVTY Stock News Headlines

May 16th Options Now Available For Revvity (RVTY)
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
See More Headlines

RVTY Stock Analysis - Frequently Asked Questions

Revvity's stock was trading at $111.61 at the start of the year. Since then, RVTY shares have decreased by 2.7% and is now trading at $108.5950.
View the best growth stocks for 2025 here
.

Revvity, Inc. (NYSE:RVTY) released its quarterly earnings results on Friday, January, 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a trailing twelve-month return on equity of 7.68%.

Revvity's board authorized a share repurchase plan on Monday, November 4th 2024, which authorizes the company to buy back $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued.

Revvity's top institutional investors include T. Rowe Price Investment Management Inc. (17.06%), Vanguard Group Inc. (11.74%), Price T Rowe Associates Inc. MD (6.27%) and Janus Henderson Group PLC (5.23%). Insiders that own company stock include Prahlad R Singh, Joel S Goldberg and Tajinder S Vohra.
View institutional ownership trends
.

Shares of RVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Revvity investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Ex-Dividend for 2/7 Dividend
1/17/2025
Last Earnings
1/31/2025
Dividend Payable
2/07/2025
Today
3/25/2025
Ex-Dividend for 5/9 Dividend
4/17/2025
Next Earnings (Estimated)
5/05/2025
Dividend Payable
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:RVTY
Employees
11,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$136.25
High Stock Price Target
$145.00
Low Stock Price Target
$120.00
Potential Upside/Downside
+25.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.77
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
49.14
Forward P/E Ratio
21.98
P/E Growth
3.82
Net Income
$270.39 million
Pretax Margin
11.48%

Debt

Sales & Book Value

Annual Sales
$2.76 billion
Cash Flow
$8.06 per share
Price / Cash Flow
13.47
Book Value
$63.00 per share
Price / Book
1.72

Miscellaneous

Free Float
120,972,000
Market Cap
$13.05 billion
Optionable
Optionable
Beta
1.06
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NYSE:RVTY) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners